These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 32958501)

  • 1. Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis.
    Wang M; Wu T; Zuo Z; You Y; Yang X; Pan L; Hu Y; Luo X; Jiang L; Xia Z; Deng M
    BMJ Support Palliat Care; 2021 Mar; 11(1):45-52. PubMed ID: 32958501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.].
    Cruciani F; Amato L; De Crescenzo F; Mitrova Z; Saulle R; Vecchi S; Davoli M
    Recenti Prog Med; 2021 Mar; 112(3):195-206. PubMed ID: 33687358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).
    Panovska-Stavridis I; Ridova N; Stojanoska T; Demiri I; Stevanovic M; Stojanovska S; Ristevska T; Dimkovski A; Filipce V; Dimovski A; Grozdanova A
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Apr; 42(1):5-18. PubMed ID: 33894123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible treatment and strategies for COVID-19: review and assessment.
    Trivedi N; Verma A; Kumar D
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12593-12608. PubMed ID: 33336780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials.
    Abrams-Downey A; Saabiye J; Vidaurrazaga M
    Eur Urol Focus; 2020 Sep; 6(5):1028-1031. PubMed ID: 32563675
    [No Abstract]   [Full Text] [Related]  

  • 6. What if COVID-19 affects the child: which weapons and how to use them.
    Anedda L; Bianchini L; Cuzzolin L; Finco G; Fanos V; Marcialis MA
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3325-3337. PubMed ID: 33928620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials.
    Bokharee N; Khan YH; Khokhar A; Mallhi TH; Alotaibi NH; Rasheed M
    Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1219-1244. PubMed ID: 33719819
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis.
    Bhattacharyya A; Kumar S; Sarma P; Kaur H; Prajapat M; Shekhar N; Bansal S; Avti P; Hazarika M; Sharma S; Mahendru D; Prakash A; Medhi B
    Indian J Pharmacol; 2020; 52(4):313-323. PubMed ID: 33078733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of SARS-CoV-2: How far have we reached?
    Ahsan W; Javed S; Bratty MA; Alhazmi HA; Najmi A
    Drug Discov Ther; 2020 May; 14(2):67-72. PubMed ID: 32336723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential strategies for combating COVID-19.
    Shamim S; Khan M; Kharaba ZJ; Ijaz M; Murtaza G
    Arch Virol; 2020 Nov; 165(11):2419-2438. PubMed ID: 32778950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of arbidol versus lopinavir/ritonavir in the treatment of coronavirus disease 2019.
    Yu M; Wang DC; Li S; Lei YH; Wei J; Huang LY
    J Med Virol; 2022 Apr; 94(4):1513-1522. PubMed ID: 34837230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 pharmacologic therapies and their safety/effectiveness according to level of evidence.
    Baroutjian A; Sanchez C; Boneva D; McKenney M; Elkbuli A
    Am J Emerg Med; 2020 Nov; 38(11):2405-2415. PubMed ID: 33041111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
    Kim MS; An MH; Kim WJ; Hwang TH
    PLoS Med; 2020 Dec; 17(12):e1003501. PubMed ID: 33378357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacology of COVID-19.
    Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
    Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic.
    Kheirabadi D; Haddad F; Mousavi-Roknabadi RS; Rezaeisadrabadi M; Dehghan H; Fazlzadeh A
    J Med Virol; 2021 May; 93(5):2705-2721. PubMed ID: 33463727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection.
    Thoguluva Chandrasekar V; Venkatesalu B; Patel HK; Spadaccini M; Manteuffel J; Ramesh M
    J Med Virol; 2021 Feb; 93(2):775-785. PubMed ID: 32667699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19.
    Maciorowski D; Idrissi SZE; Gupta Y; Medernach BJ; Burns MB; Becker DP; Durvasula R; Kempaiah P
    SLAS Discov; 2020 Dec; 25(10):1108-1122. PubMed ID: 32942923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
    Yadav AK; Wen S; Xu X; Yu L
    Ann Palliat Med; 2021 Jan; 10(1):707-720. PubMed ID: 33440983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors.
    Rogado J; Gullón P; Obispo B; Serrano G; Lara MÁ
    Eur J Cancer; 2021 May; 148():58-60. PubMed ID: 33735810
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics-a review.
    Raj CTD; Kandaswamy DK; Danduga RCSR; Rajasabapathy R; James RA
    Arch Microbiol; 2021 Jul; 203(5):2043-2057. PubMed ID: 33555378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.